Amgen's Imdelltra granted FDA accelerated approval to treat small cell lung cancer
More than 234,000 new cases of lung cancer are expected to be diagnosed in the US this year
Source: pmlive.com
Project Orbis News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Project Orbis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Project Orbis Today - Breaking & Trending Today
Alectinib: Adjuvant Treatment for Lung Cancer Approved by US FDA
Alectinib approved by US FDA for auxiliary treatment of patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) who underwent tumor resection.
Source: medindia.net
FDA Approves New Indication for AstraZeneca and Daiichi Sankyo's Cancer Drug ENHERTU | Goodwin
On April 5, the FDA granted accelerated approval to AstraZeneca and Daiichi Sankyo’s ENHERTU (trastuzumab deruxtecan) for adult patients with unresectable or metastatic...
Source: jdsupra.com
AstraZeneca Plc's Enhertu approved in the US for HER2+ solid tumours
AstraZeneca plc and Daiichi Sankyo's Enhertu has gained US approval for treating HER2-positive solid tumours, marking a significant advancement in cancer treatment.
Source: directorstalkinterviews.com
Daiichi Sankyo : ENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2 Positive Solid Tumors (375.5KB -April 05, 2024 at 11:34 pm EDT
Press Release ENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2...
Source: marketscreener.com